Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2026-01-13 @ 3:06 PM
Study NCT ID:
NCT05919212
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2023-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
5382
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None